Taro Pharmaceutical Industries Ltd. (TARO) Sues Synerx Pharma, Karalex Pharma and DPT Laboratories, Ltd. for Patent Infringement  
7/27/2009 10:28:23 AM

HAWTHORNE, N.Y, July 27, 2009 (GLOBE NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company,") (Pink Sheets:TAROF) said today that it has filed a lawsuit against Synerx Pharma, LLC, DPT Laboratories, Ltd. and Karalex Pharma, LLC (a subsidiary of Eagle Pharmaceuticals, Inc.) in the United States District Court for New Jersey for infringement of its United States Patent No. 7,560,445 covering its Ovide(r) (malathion) Lotion, 0.5%. The suit alleges that the defendants' generic malathion lotion, 0.5%, infringes on Taro's patent, either directly or indirectly. Taro seeks injunctive relief as well as damages for infringement of its patent by the defendants.